Effects of Data-Based Interdisciplinary Medication Reviews on the Prevalence and pattern of Neuroleptic Drug Use with Institutionalized Mentally Retarded Persons
Restricted accessResearch articleFirst published online April, 1982
Effects of Data-Based Interdisciplinary Medication Reviews on the Prevalence and pattern of Neuroleptic Drug Use with Institutionalized Mentally Retarded Persons
The effects of a data-based interdisciplinary approach to medication reviews were examined. The subjects were 250 institutionalized mentally retarded adolescents and adults. Dependent measures were (a) number of individuals receiving neuroleptic drugs, (b) mean daily drug dose, (c) number of individuals receiving dosage increases or decreases, and (d) number of individuals able to be maintained on lowered dosages or no drug at all. The study used an ABAB design and covered a consecutive 25-month period. The findings were that data-based reviews resulted in decreased numbers of individuals receiving neuroleptic drugs, lower mean daily dosages, and less frequent dosage increases. Ninety-seven percent of the individuals receiving drug discontinuation or dosage decreases were not placed back on a drug or did not receive dosage increases. Additional advantages of the review process are discussed.
Get full access to this article
View all access options for this article.
References
1.
BreuningS. E. (in press). An applied dose response curve of thioridazine use with the mentally retarded. Aggressive, self-stimulatory, intellectual, and workshop behaviors. Psychopharmacology Bulletin.
2.
BreuningS. E., & DavidsonN. A. (1981). Effects of psychotropic drugs on the intelligence test performance of institutionalized retarded adults. American Journal of Mental Deficiency, 85, 575–579.
3.
BreuningS. E., FergusonD. G., & CullariS. (1980). Analysis of single-double blind procedures, maintenance of placebo effects, and drug induced dyskinesia with mentally retarded persons. Applied Research in Mental Retardation, 1, 175–192.
4.
BreuningS. E., O'NeillM. J., & FergusonD. G. (1980). Comparison of psychotropic drug, response cost, and psychotropic drug plus response cost procedures for controlling institutionalized retarded persons. Applied Research in Mental Retardation, 1, 253–268.
5.
CrosbyK. G. (1976). Essentials of active programming. Mental Retardation, 14, 3–9.
6.
DavisJ. M. (1976). Comparative dosages costs of antipsychotic medication. Archives of General Psychiatry, 33, 858–861.
7.
DavisV. J., CullariS., & BreuningS. E. (in press). Drug use in community foster and group homes. In BreuningS. E. & PolingA. D. (Eds.), Drugs and Mental Retardation. Springfield, Ill: Charles C. Thomas.
8.
FergusonD. G., & BreuningS. E. (in press). Antipsychotic and antianxiety drugs. In BreuningS. E. & PolingA. D. (Eds.), Drugs and Mental Retardation. Springfield, Ill: Charles C. Thomas.
9.
FieldingL. T., MurphyR. J., ReaganM. W., & PetersonT. L. (1980). An assessment program to reduce drug use with the mentally retarded. Hospital and Community Psychiatry, 31, 771–773.
10.
GualtieriC. T., BarnhillJ., McGimseyJ., & SchellD. (1980). Tardive dyskinesia in children. Journal of the American Academy of Child Psychiatry, 19, 491–510.
11.
LaMendolaW., ZahariaE. E., & CarverM. (1980). Reducing psychotropic drug use in an institution for the retarded. Hospital and Community Psychiatry, 31, 271–272.
12.
LipmanR. S. (1970). The use of psychopharmacological agents in residential facilities for the retarded. In MenolacinoF. J. (Ed.), Psychiatric Approaches to Mental Retardation. New York: Basic Books.
13.
MarholinD., TouchetteP. E., & StewartR. M. (1979). Withdrawal of chronic chlorpromazine medication: An experimental analysis. Journal of Applied Behavior Analysis, 12, 159–171.
14.
McConaheyO. L., ThompsonT., & ZimmermanR. (1977). A token system for retarded women: Behavior therapy, drug administration, and their combination. In ThompsonT. & GrabowskiJ. (Eds.), Behavior modification of the mentally retarded (2nd ed.). New York: Oxford University Press.
15.
ScrantonT. R., HajicekJ. O., & WolcottG. J. (1978). The physician and teacher as team: Assessing the effects of medication. Journal of Learning Disabilities, 11, 21–25.
16.
SpragueR. L. (1977). Overview of psychopharmacology for the retarded in the United States. In MittlerP. (Ed.), Research to practice in mental retardation: Biomedical aspects (Vol. 3). Baltimore: University Park Press.
17.
SpragueR. L., & GadowK. D. (1976). The role of teacher in drug treatment. School Review, 85, 109–140.
18.
SpragueR. L., & WerryJ. S. (1971). Methodology of psychopharmacological studies with the retarded. In EllisN. R. (Ed.), International review of research in mental retardation (Vol. 5). New York: Academic Press.
19.
SulzbacherS. I. (1973). Psychotropic medication with children: An evaluation of procedural bias in results of reported studies. Pediatrics, 51, 513–517.
20.
Welsch v. Likens, 550 1. 2d 1122 (8th cir. 1977).
21.
WinsbergB. G., & YepesL. E. (1978). Antipsychotics (major tranquilizers, neuroleptics). In WerryJ. S. (Ed.), Pediatric psychopharmacology: The use of behavior modifying drugs in children. New York: Bruner/Mazel.
